A phase I study of oral LY293111 given daily in combination with irinotecan in patients with solid tumours. (Q54439319)

From Wikidata
Jump to navigation Jump to search
scientific article published on 5 December 2006
edit
Language Label Description Also known as
English
A phase I study of oral LY293111 given daily in combination with irinotecan in patients with solid tumours.
scientific article published on 5 December 2006

    Statements

    A phase I study of oral LY293111 given daily in combination with irinotecan in patients with solid tumours. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit